Why Marshall
Leadership
Dean Geoffrey Garrett
Dean's Cabinet
Boards
Real-World Learning
Human Leadership
Tech Fluency
Global Opportunities
Diversity, Equity and Inclusion
Teaching + Innovation
Experiential Learning Center
Open Expression Statement
Programs
Undergraduate Programs
Admissions
Degrees
BS Business Administration (BUAD)
Business Emphases
BS Accounting (ACCT)
World Bachelor in Business (WBB)
BS Business of Cinematic Arts (BCA)
BS Artificial Intelligence for Business (BUAI)
Undergraduate Minors
Graduate Programs
MBA Programs
Full-Time MBA (FTMBA)
Executive MBA (EMBA)
Part-Time MBA (MBA.PM)
International MBA (IBEAR)
Online MBA (OMBA)
Specialized Masters
MS Business Administration (MSBUSAD)
MS Business Analytics (MSBA)
MS Entrepreneurship + Innovation (MSEI)
MS Finance (MSF)
MS Global Supply Chain Management (MSGSCM)
MS Marketing (MSMKT)
MS Social Entrepreneurship (MSSE)
Master of Business for Veterans (MBV)
Master of Management Studies (MMS)
Accounting Masters
Master of Accounting (MAcc)
Master of Business Taxation (MBT)
Master of Business Taxation for Working Professionals (MBT.WP)
PhD Program
Accounting
Data Sciences + Operations
Finance
Management + Organization
Marketing
Graduate Certificates
GC in Business Analytics
GC in Financial Analysis + Valuation
GC in Management Studies
GC in Marketing
GC in Optimization + Supply Chain Management
GC in Strategy + Management Consulting
GC in Sustainability + Business
GC in Technology Commercialization
GC in Library and Information Management – Online
Executive Education
Departments
Business Communication (BUCO)
Faculty
Data Sciences and Operations (DSO)
Finance + Business Economics (FBE)
Leventhal School of Accounting (ACCT)
Lloyd Greif Center for Entrepreneurial Studies (BAEP)
Management and Organization (MOR)
Marketing (MKT)
Institutes + Centers
Randall R. Kendrick Global Supply Chain Institute
Peter Arkley Institute for Risk Management
VanEck Digital Assets Initiative
Institute for Outlier Research in Business
Lloyd Greif Center for Entrepreneurial Studies
Incubate USC
USC Marshall Venture Fund
Brittingham Social Enterprise Lab
Neely Center for Ethical Leadership and Decision Making
Center for Effective Organizations
Center for Global Innovation
Center for Investment Studies
Initiative on Digital Competition
Trojan Network
Recruiting
Undergraduate
Graduate
Career Services
Giving + Support
Alumni Engagement + Resources
Student Organizations
Yehuda Bassok's research interests include supply chain management, design and analysis of purchasing contracts, management of centralized and decentralized inventory systems, and bargaining within supply chains. His research has been published in many top journals, including Management Science and Operations Research. Prior to joining USC, he was on the faculty of Northwestern University and a visiting professor at the University of Washington. Professor Bassok served as chief system analyst of SES, a company that specialized in developing real time data collection and scheduling systems. Professor Bassok has received several teaching awards, including Marshall's Golden Apple Award in 2003.
RESEARCH + PUBLICATIONS
We develop a general framwork to predict the demand for a new drug when past demand data is not available. Our method is based on demogarphic data, logistic ability and training level of the population, physicians and Parmacists.
This is scholarly book the summarizes my work in this area and some new topics. I hope to finish it by May this year. It will include about 150-175 pages.
Developing and producing drugs and vaccines is a risky business. First, success rates in developing new drugs and vaccines are low. Second, investments in research and development, capacity and production are very large. They are usually made long before the actual demand is known to the investor and thus the investor is assuming the demand risk. Finally these investments are irreversible. If the demand turns to be high investors enjoy high profits. But, if the demand does not materialize investors lose hundreds of million of dollars. These risks are universal and widespread all over the world: in high income countries as well as medium and low income countries. The difference between the low income and high income countries is that in the low income countries there are no markets for drugs and vaccines: neither the population nor the government can afford to pay the full price of drugs and vaccines. Thus, donors must provide a subsidy and pay the lion share of the cost of delivering the drugs and vaccines in the low income countries. There are many different mechanisms in which donors can subsidize drugs and vaccines. These mechanisms can affect the motivation of pharmaceuticals to invest in research and development, the demand for the drug or vaccine, the corruption levels and several other important components of the health system. The objective of this study is to build on an existing mechanism that is designed to encourage pharmaceutical companies to invest in the development and production of new vaccines and drugs. Our contribution is in ensuring that grand corruption is minimized, that donors assume acceptable risks and that incentives of all players are aligned.